Mark T. Iwicki - Jun 28, 2021 Form 4 Insider Report for Kala Pharmaceuticals, Inc. (KALA)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Eric Trachtenberg, Attorney-in-Fact
Stock symbol
KALA
Transactions as of
Jun 28, 2021
Transactions value $
-$43,771
Form type
4
Date filed
6/29/2021, 05:25 PM
Previous filing
Jun 3, 2021
Next filing
Jun 29, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KALA Common Stock Sale -$43.8K -7.59K -2.5% $5.77 296K Jun 28, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of the reporting person's restricted stock units granted on June 25, 2020.
F2 Includes 279,080 unvested RSUs.